“…Since no entirely specific agents of this type are available two steroids with different mechanisms of antiprogestational activity and different spectra of other biological activities were used. RMI 12,936 (17ß-hydroxy-7a methyl androst-5-en-3-one) is an antiprogestational steroid with weak oestrogenic, antioestrogenic and androgenic activities; it inhibits progesterone secretion and may be metabolized to a further compound which antagonizes the effects of progesterone (Kendle, 1975(Kendle, , 1976(Kendle, , 1978Grunwell, Benson, Johnston & Petrow, 1976;Geddes, Kendle, Shanks & Steven, 1979). R2323 (13-ethyl-17-hydroxy-18,19-dinor-17a-pregna-4,9,ll-trien-20-yn-3-one) has weak oestrogenic, weak andro¬ genic and antioestrogenic activities and is a competitive antagonist of progesterone (Sakiz & Azadian-Boulanger, 1971;Sakiz, Azadian-Boulanger & Raynaud, 1974;Raynaud et al, 1975).…”